BHFAL — Brighthouse Financial, Inc.

Brighthouse Financial (BHFAL) Q2 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Adjusted Earnings: $198 million ($3.43 per share), down from $245 million in Q1 2025 and $346 million in Q2 2024.
• Total Annuity Sales: $2.6 billion, a 16% sequential increase and an 8% year-over-year increase.
• Shield Sales: $1.9 billion in Q2, year-to-date total of $3.9 billion, consistent with the same period last year.
• Life Insurance Sales: $33 million in Q2, contributing to record year-to-date sales of $69 million (up 21% YoY).
• Combined Risk-Based Capital (RBC) Ratio: Estimated between 405% and 425%, within the target range of 400% to 450%.
• Total Adjusted Capital (TAC): Approximately $5.6 billion, up from $5.5 billion at the end of Q1 2025.
• Corporate Expenses: $202 million, down from $239 million in Q1 2025.

2. Strategic Updates and Business Highlights

• Continued execution of capital-focused strategic initiatives aimed at improving capital efficiency and managing risk.
• Strong performance in annuity and life insurance sales, with a focus on maintaining expense discipline.
• Successful deposits through BlackRock's LifePath Paycheck product, totaling $176 million in Q2.
• Ongoing work to simplify and revise the hedging strategy for variable annuities and Shield products, with completion expected by the end of September 2025.

3. Forward Guidance and Outlook

• Management remains optimistic about the sales trajectory, particularly in annuities and life insurance, with no changes to the current business strategy.
• Anticipation of continued strong performance in the third quarter, following a solid second quarter.
• Future cash flow projections are not expected until 2026, pending the completion of several strategic initiatives.

4. Bad News, Challenges, or Points of Concern

• Adjusted Earnings Decline: Earnings fell significantly below quarterly average run rate expectations due to lower alternative investment income and underwriting margins.
• Claims Severity: Increased claims severity noted in both Life and Run-off segments, with severity approximately 18% higher than normal levels.
• Hedging Strategy Transition: While management believes the changes will lead to better risk management, there are concerns about potential impacts on capital ratios and balance sheet stability during the transition.
• Competitive Pressures: Noted increased competition in the annuity market, which may affect future sales growth.

5. Notable Q&A Insights

• Actuarial Review: Management is in the process of conducting an actuarial review, with no updates provided yet.
• Buybacks: The company has paused share repurchases since May 2025, with future buyback plans dependent on capital flexibility.
• Sales Strategy: Despite a noted slowdown in Shield sales, management remains confident in the product's value and their pricing discipline.
• Capital Management: Discussions around the Delaware Reinsurance Company indicate a focus on cash flow testing and regulatory communication regarding capital distributions.
• Hedging Changes: The transition to a separate hedging strategy for VA and Shield products is expected to enhance transparency and reduce volatility in results over time.

Overall, Brighthouse Financial reported solid sales growth but faced challenges in earnings and claims management, with strategic initiatives aimed at improving capital efficiency and risk management underway.